属地市场监管部门是否对上述情况进行了调查处理？记者近日获悉，曾有市民咨询相关情况处理进度， 南海区市场监管局工作人员回复显示，该局已对相关案件进行了跟进，发现当事人在澳洲注册空壳公 司，以空壳公司名义号称"奶粉"为进口，实际为国内生产。此外，当事人所售"奶粉"，与纯奶粉在营养 结构上存在差异。 号称"澳洲品牌，澳大利亚原生牧场直采"的"奶粉"，被媒体打假实际产地在国内，官方是否对其进行调 查处理？记者近日获悉，上述"奶粉"委托总代理商"佛山市澳可佳商贸有限公司"所在地市场监管部门， 已经跟进了相关案件，当事人被处以150万元的罚款。 2025年5月，新京报报道，一款在直播间销售，号称是"澳洲品牌的蓝胖子牛奶粉，澳大利亚原生牧场直 采，新鲜牛奶直接喷粉而成"的"Melodicent牛奶营养粉"，实际总代理商、加工方均位于国内，且产品类 型为"方便食品"，并非乳粉或调制乳粉。 公开资料显示，上述产品总代理商——佛山市澳可佳商贸有限公司注册地址位于广东省佛山市西樵镇， 法定代表人为张文恒（持股50%），张雅宇（持股50%）。 据悉，由于案涉多个公司，市场监管部门已责令当事人停止违法行为，并对当事人处以150万元的罚 ...

Core Viewpoint - The controversy surrounding the sale of "Wanshi Mahuang Chicken" by the "Yuhui Tongxing" livestream has raised questions about the authenticity and classification of the product, leading to scrutiny from the Anhui Liuzhou Mahuang Chicken Industry Association [1][6]. Group 1: Product Quality and Classification - The "Yuhui Tongxing" customer service stated that the product "Bai Shixuan Dabeishan Yellow Butter Chicken" is of qualified quality, with no issues related to veterinary drug residues, antibiotics, or banned substances [3]. - The term "Mahuang Chicken" is described as an industry colloquial name, referring to chickens with specific feather characteristics, and is widely raised across multiple provinces [5]. - The Anhui Liuzhou Mahuang Chicken Industry Association has expressed concerns that the product being sold does not match the recognized "Wanshi Mahuang Chicken" breed, as indicated by their findings that only a limited number of Mahuang chickens are raised in the region [6][9]. Group 2: Industry Standards and Regulations - The Liuzhou Agricultural and Rural Bureau has set a target for the local Mahuang chicken population to reach 77 million by 2024, with significant production and economic potential highlighted [5]. - The association's statement indicated that they have not found any suppliers for the "Dabeishan Yellow Butter Chicken" that align with their recognized standards, suggesting a lack of legitimate sourcing [6][7]. - The local government has been involved in efforts to protect and promote the "Hua Nan Mahuang Chicken" breed, which is recognized as a protected variety, while "Wanshi Mahuang Chicken" lacks such designation [10]. Group 3: Ongoing Investigations - Following the controversy, market supervision authorities in Anhui's Huoqiu and Feixi counties have initiated investigations into the matter [11].

Core Viewpoint - The article discusses the controversy surrounding the "Kangzitou Yunnan Bencao Yatongning Herbal Care Spray," which claims to treat various dental issues but has been criticized for misleading advertising and lack of medical efficacy [1][5][11] Product Claims and Issues - The product was marketed as a solution for multiple dental pain issues, including pain while eating or drinking, cavities, and gum inflammation, claiming to be more convenient than visiting a dentist [1][2][5] - Despite the removal of promotional videos from the sales page, customer service continues to assert that the product can "gradually repair and protect teeth" and suppress bacterial growth [2][6][9] Regulatory and Compliance Concerns - The product is not classified as a medicine but rather as a herbal mouth and nasal care liquid, with its formulation based on various herbal ingredients [5] - The product's packaging states it cannot replace medicine, yet it still promotes effectiveness against multiple oral diseases, which raises legal concerns under Chinese advertising laws [5][11] - The seller, Wuhan Maizhenxuan Network Technology Co., Ltd., has been listed in an abnormal business operation directory due to not operating at its registered address [10] Expert Opinions - Medical professionals have expressed skepticism regarding the product's claims, stating that a single product cannot effectively address the diverse mechanisms behind various dental issues [11]

Core Viewpoint - The Shanghai Consumer Protection Committee has raised concerns regarding the authenticity of Antarctic krill oil products marketed by Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd, leading to an investigation and potential legal actions against the involved parties [4][5][9]. Group 1: Product Issues - A product labeled as "99% high-purity Antarctic krill oil" was found to have a phospholipid content of 0%, despite claims of 43% on its packaging [4][5]. - The product's marketing included misleading statements such as "high content," "imported from Chile," and "highly purified," which were proven to be false [5]. Group 2: Company Accountability - Anhui Hab Pharmaceutical Co., Ltd, the manufacturer, admitted that the product did not contain the claimed Antarctic krill oil during production [4][5]. - Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd, the distributor, denied knowledge of the alleged fraudulent activities and attempted to deflect responsibility [4][5]. Group 3: Regulatory Actions - The Shanghai Consumer Protection Committee has urged the distributor to conduct a self-examination, inform consumers of the situation, issue an apology, and recall the problematic products [5]. - The committee has also notified relevant regulatory authorities in Sichuan to monitor the situation [5]. Group 4: Company Background - Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd was established in June 2000 and is a member of the Beijing Tongrentang Group, with a 51% stake held by Beijing Tongrentang Health Pharmaceutical Co., Ltd [7][8]. - The company has faced scrutiny in the past for similar issues, including false advertising related to fish oil products [10].

Core Viewpoint - The Shanghai Consumer Protection Commission has taken action against a product labeled as "99% high-purity Antarctic krill oil" from Beijing Tongrentang, revealing significant discrepancies between the product's claims and its actual content [1][4]. Group 1: Product Misrepresentation - A product marketed as having a phospholipid content of 43% was found to contain no actual Antarctic krill oil, indicating a serious misrepresentation [5]. - The product's promotional materials claimed high purity and quality, including statements like "1 capsule ≈ 100 krill," which were proven to be misleading [4][5]. Group 2: Company Accountability - The manufacturer, Anhui Habao Pharmaceutical Co., admitted that the product did not contain the advertised Antarctic krill oil and that the procurement price was significantly lower than normal [5]. - Beijing Tongrentang (Sichuan) Health Pharmaceutical Co. distanced itself from the issue during discussions, claiming ignorance of the alleged fraudulent activities [5][6]. Group 3: Regulatory Response - The Shanghai Consumer Protection Commission has urged Beijing Tongrentang (Sichuan) to conduct a self-examination, apologize to consumers, and recall the problematic products [6]. - The commission has also notified relevant regulatory authorities in Sichuan to monitor the situation closely [6]. Group 4: Legal Actions - Following the incident, Beijing Tongrentang Health Pharmaceutical Co. announced that it would take legal action against the involved parties for unauthorized use of its brand name and to protect consumer rights [11].

Core Viewpoint - The article highlights the swift action taken by the Xiamen Market Supervision Administration in response to reports of false advertising related to "imported" blood sugar control drinks, leading to the removal of certain products from the market and ongoing investigations into the involved companies [1][4][5]. Regulatory Response - The Xiamen Market Supervision Administration has initiated an investigation into the companies involved in the false advertising of blood sugar control products, specifically targeting the "Kongtangwei" and "Breorqy" brands [1][5]. - The regulatory body has mandated the removal of product links and is conducting further investigations to address the reported violations [1][5][6]. Market Impact - The article notes that the false claims made by these products, such as being "imported" and having extraordinary effects on blood sugar control, misled consumers and posed challenges to diabetes treatment [4][5]. - The cost of the "Kongtangwei" product is estimated to be less than 10 yuan, while it is sold for over 100 yuan, indicating significant markup based on misleading claims [4]. Ongoing Issues - Despite the removal of certain products, many others continue to be sold with unchanged promotional content, indicating a persistent issue with false advertising in the market [7][8]. - The article points out that various other products, including chromium supplements and herbal teas, also make unverified claims regarding their effectiveness in controlling blood sugar levels [5][8]. Recommendations for Improvement - Experts suggest that regulatory efforts need to be strengthened, particularly in enhancing the oversight of e-commerce platforms to prevent the sale of products with exaggerated claims [8][9]. - There is a call for improved collaboration among regulatory bodies across different regions to ensure comprehensive monitoring and enforcement against misleading advertising practices [8][9].

Core Viewpoint - The article highlights the issue of false advertising in fish oil products sold through live streaming, prompting regulatory actions from the State Administration for Market Regulation (SAMR) in China [1] Regulatory Actions - SAMR has initiated enforcement checks in provinces including Anhui, Shanghai, Zhejiang, and Guangdong in response to the reported false claims regarding fish oil products [1] - Three specific non-compliant fish oil products were identified: "Huacheng·Astaxanthin Deep Sea Fish Oil Gummy Candy," "Huacheng·Deep Sea Polyunsaturated Fish Oil Gummy Candy," and "Deep Sea Polyunsaturated Fish Oil (Sugar-Free) Gummy Candy" [1] - The Anhui market regulatory department conducted immediate inspections on the involved companies, leading to investigations against Anhui Gusu Yuan Pharmaceutical Co., Ltd. and Anhui Runfeng Health Technology Co., Ltd. [1] Legal Violations - The companies are being investigated for potential violations of the Food Safety Law of the People's Republic of China and the Anti-Unfair Competition Law [1] - Local market regulatory authorities have engaged with platform representatives to address the illegal product listings, and false advertising cases have been referred to relevant market regulatory departments for legal action [1]